Infectious Disease & Vaccines
Part of Biotech - Drug Development
 MRK | Merck & Co., Inc. | $356.0b | $141.83 | +0.8% | 4.9M |
 GILD | Gilead Sciences Inc | $179.5b | $157.79 | -0.6% | 2.7M |
 PFE | Pfizer Inc. | $158.5b | $29.67 | -0.4% | 10.8M |
 MRNA | Moderna, Inc. Common Stock | $75.9b | $204.83 | +1.0% | 13.4M |
 SMMT | Summit Therapeutics Inc. Common Stock | $13.4b | $15.24 | +4.2% | 3.5M |
 PCVX | Vaxcyte, Inc. Common Stock | $8.4b | $60.00 | 0.0% | 1.0M |
 BCRX | BioCryst Pharmaceuticals Inc | $2.1b | $8.06 | +2.3% | 5.2M |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.9b | $11.26 | +1.1% | 711.5K |
 NVAX | Novavax Inc | $1.7b | $10.02 | +5.5% | 4.3M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.9b | $4.29 | +1.5% | 776.6K |
 CRMD | CorMedix Inc. | $0.6b | $8.04 | +1.2% | 529.3K |
 ASMB | Assembly Biosciences, Inc | $458.9m | $20.30 | +2.4% | 97.4K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $411.5m | $4.16 | -1.0% | 112.6K |
 ENTA | Enanta Pharmaceuticals, Inc | $377.5m | $12.02 | +0.3% | 168.0K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $370.4m | $11.37 | +13.3% | 470.7K |
 EBS | Emergent Biosolutions, Inc. | $324.6m | $6.70 | +4.9% | 696.8K |
 SIGA | SIGA Technologies Inc. | $242.9m | $3.21 | +1.7% | 258.0K |
 IVVD | Invivyd, Inc. Common Stock | $242.3m | $0.60 | +0.3% | 3.0M |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $215.5m | $3.65 | +0.3% | 133.0K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $152.8m | $5.41 | +1.1% | 600.9K |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $130.9m | $3.55 | +2.8% | 24.3K |
 INO | Inovio Pharmaceuticals, Inc. | $119.9m | $0.91 | +2.9% | 2.6M |
 ZTEK | Zentek Ltd. Common Stock | $85.3m | $0.49 | 0.0% | N/A |
 SPRO | Spero Therapeutics, Inc. Common Stock | $69.3m | $1.10 | +2.3% | 401.8K |
 XBIT | XBiotech Inc | $66.8m | $1.85 | 0.0% | 44.3K |
 SCYX | SCYNEXIS, Inc. | $50.9m | $3.81 | 0.0% | 35.0K |
 IBO | Impact BioMedical, Inc. | $45.5m | $3.83 | +0.3% | 9.6K |
 TVGN | Tevogen Inc. Common Stock | $45.5m | $6.43 | 0.0% | 790 |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $34.6m | $4.71 | 0.0% | 7.7K |
 NNVC | NanoViricides Inc. | $32.7m | $1.46 | +7.4% | 182.7K |
 MCRB | Seres Therapeutics, Inc. | $29.5m | $1.81 | -8.6% | 140.9K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $23.4m | $2.41 | 0.0% | 17.8K |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $23.3m | $8.86 | 0.0% | 3.9K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $22.1m | $0.99 | +0.6% | 12.5K |
 MBRX | Moleculin Biotech, Inc. | $9.9m | $8.71 | +10.5% | 114.3K |
 TRAW | Traws Pharma, Inc. Common Stock | $8.7m | $0.34 | -8.9% | 119.2K |
 SNGX | Soligenix, Inc. Common Stock | $8.0m | $0.37 | +2.8% | 58.0K |
 CODX | Co-Diagnostics, Inc. Common Stock | $7.5m | $0.46 | -15.8% | 1.1M |
 IMNN | Imunon, Inc. Common Stock | $7.2m | $0.92 | -23.8% | 441.6K |
 AIM | AIM ImmunoTech Inc. | $7.2m | $0.17 | +2.2% | 166.4K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $6.4m | $0.80 | 0.0% | N/A |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $5.5m | $1.06 | 0.0% | 49.3K |
 XBIO | Xenetic Biosciences, Inc. | $5.2m | $1.84 | 0.0% | 10.0K |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $4.9m | $0.66 | -21.5% | 15.8M |
 AEMD | AETHLON MEDICAL INC | $4.6m | $5.21 | 0.0% | 20.2K |
 PHGE | BiomX Inc. | $3.8m | $1.88 | 0.0% | N/A |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 GOVX | GeoVax Labs, Inc. New | $2.9m | $0.20 | +5.0% | 150.8K |
 SBFM | Sunshine Biopharma Inc. | $2.6m | $2.90 | +9.4% | 524.4K |
 LABT | Lakewood-Amedex Biotherapeutics Inc. Common Stock | $2.3m | $0.28 | -4.1% | 1.0M |